Zhitong Finance App News, Unnamed Pharmaceutical (002581.SZ) issued an announcement. The company held the 24th meeting of the 5th board of directors on May 30, 2024 to review and pass the “Proposal on Withdrawal from the M&A Fund”. The board of directors of the company agreed to withdraw from the Shenzhen Qianhai Weiming Pharmaceutical Industry M&A Fund (limited partnership) (“Qianhai Weiming M&A Fund” for short).

Since the M&A fund has not actually operated since registration, has not injected any capital, and has not invested in any projects, the purpose of establishing the fund can no longer be achieved. According to the company's actual situation, in order to optimize the company's organizational structure and management system, the company plans to withdraw from the Shenzhen Qianhai Weiming Pharmaceutical Industry M&A Fund (limited partnership).